Pharmafile Logo
Pharmafocus logo
Advanced Search

uterine fibroids

Showing 3 posts of 3 posts found.

Uterine fibroids and the cost of silence

October 9, 2025
Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …

Feature

Pfizer and Myovant’s menstrual blood loss treatment reports 78% effectiveness

March 24, 2021
Research and Development Myovant, Pfizer, Phase III trial, fibroids, uterine fibroids

Pfizer and Myovant Science’s relugolix treatment to reduce menstrual blood loss in women with uterine fibroids has shown promising results …

News
hospital

Repros Therapeutics says positive results from Phase II trial of uterine fibroids drug; shares jump

April 15, 2016
Medical Communications, Research and Development Repros Therapeutics, Shares, US FDA, drug trial, uterine fibroids

Shares in Repros Therapeutics (Nasdaq: RPRX) surged to close over 18% Thursday after the company announced positive mid-stage trial results …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025